drugset
Drugs / Mycobacterium bovis bacille Calmette-Guérin
last change Dec 2025 re-read 1 minute ago

Mycobacterium bovis bacille Calmette-Guérin

also known as BCG

Vaccine

Developed for
tuberculosis
Investigated by
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · International Maternal Pediatric Adolescent AIDS Clinical Trials Group · National Institute of Allergy and Infectious Diseases (NIAID) · National Institute of Mental Health (NIMH)

Trials 1 · a red edge is where a trial was stopped

today NCT05539989 · Ph 1/2
2026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT05539989 Dec 2025 HIV infectious disease, tuberculosis International Maternal Pediatric Adolescent AIDS Clinical Trials Group Withdrawn No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Mycobacterium bovis bacille Calmette-Guérin “Mycobacterium bovis bacille Calmette-Guérin (BCG) revaccination” NCT05539989 ↗
Known as BCG ClinicalTrials.gov intervention name — accepted as the source's own label NCT05539989 ↗
Modality Vaccine “BCG revaccination” NCT05539989 ↗